Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia

INTRODUCTION: Prostate cancer (PCa) is one of the most common malignancies in men worldwide. Serum prostate specific antigen (PSA) level has been extensively used as a biomarker to detect PCa. However, PSA is not cancer-specific and various non-malignant conditions, including benign prostatic hyperp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Rambla, Clara, Puchades-Carrasco, Leonor, García-Flores, María, Rubio-Briones, José, López-Guerrero, José Antonio, Pineda-Lucena, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533870/
https://www.ncbi.nlm.nih.gov/pubmed/28804274
http://dx.doi.org/10.1007/s11306-017-1194-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533870/
https://www.ncbi.nlm.nih.gov/pubmed/28804274
http://dx.doi.org/10.1007/s11306-017-1194-y

Ejemplares similares